Synthesis, Anti-Bacterial and Molecular Docking Studies of Arylated Butyl 2-Bromoisonicotinate Against Clinical Isolates of ESBL-Producing Escherichia coli ST405 and Methicillin-Resistant Staphylococcus aureus .
Shazia NaheedIrum Umar DinMuhammad Usman QamarNasir RasoolMatloob AhmadMuhammad BilalAqsa KhalidGulraiz AhmadMagdi E A ZakiMagdi E A ZakiPublished in: Infection and drug resistance (2023)
ST405 and MRSA strains. After the in-vivo trial, this substance might offer an alternative therapeutic option.
Keyphrases